In 2021, the digital health industry saw an influx of funding, surpassing 2020’s full-year total after the second quarter.
So what are we in for next year? Will digital health funding continue at the same rapid pace in 2022? MobiHealthNews asked digital health leaders and executives their predictions about funding for next year. Be sure to check out their thoughts on the expansion of virtual...
Nurx, a direct-to-consumer women’s health company best known for its online birth control prescriptions, launched a Skill for Amazon Alexa focused on sexual and reproductive health as well as pill reminders.
The Nurx Birth Control and Sexual Health Knowledge Skill reminds patients to take their birth control pills daily at the time of their choice, which is critical to preventing unplanned...
Direct-to-consumer women’s health company Nurx is once again broadening its offerings, this time into urgent care with the launch of Nurx Now.
Kicking off Nurx Now, the company will provide access to emergency contraception with urgent care telehealth appointments available seven days a week and with overnight shipping.
Nurx already offers two morning-after pills, New Day (a generic version of...
Direct-to-consumer women’s healthcare platform Nurx has expanded its at-home dermatology services to include treatment for rosacea.
Nurx launched the first of its dermatology treatment services earlier this year for acne, and through that found a significant portion of patients mistook their rosacea for acne when seeking treatment, the company said in its announcement.
“We know that many of our...
Data shows that women control the bulk of healthcare spending in the U.S., which has given women the nickname 'chief medical officer' of the family. However, when it comes to digital health, only 14% of deals were closed by women-led digital health startups in 2019, according to Rock Health.
While women-led companies have made strides in the digital health world, these companies often struggle to...
NurX CEO Varsha Rao joins host Jonah Comstock and MobiHealthNews Managing Editor Laura Lovett to discuss her telehealth company's journey from a laser focus on contraception to a broader play for women's (and men's) health that includes dermatology and migraines.
Along the way, we also discuss broader trends in telehealth, the challenges of femtech and NurX's foray into COVID-19 testing.
Like...
The digital health space is continuing to see the rise in women’s health companies. One of those bourgeoning companies is Nurx, which has already raked in a cool $113 million in venture funding.
MobiHealthNews sat down with Nurx’s CEO Varsha Rao to talk about what we saw in 2020 and what she predicts will happen to the digital women’s health space in 2021.
Looking back at last year Rao said she...
Nurx, a women’s health platform best known for using telemedicine to connect patients with contraceptives and STI testing, is dipping into the migraine space. Today it launched a new service that lets patients virtually connect with a provider and develop an individualized migraine management plan.
Patients pay a $60 annual fee, which includes online medical consultations, a video exam where...
Nurx, a startup known for online purchase and delivery of home health tests, birth control and other sensitive treatments for women, has tacked on another $22.5 million in Series C funding.
Closed in May, the raise included new backers Trustbridge, Comcast Ventures and Wittington Ventures, as well as prior backers Union Square Ventures and Kleiner Perkins Digital Growth Fund. This brings the...
Last week saw a number of diagnostic testing startups, telehealth providers and others announce new services that would deliver at-home COVID-19 testing-kits to consumers. But the majority of these of offerings have since been rescinded or hang in doubt thanks to new warnings and regulatory clarifications issued this weekend by the FDA.
On Friday evening, the agency released an alert to consumers...
.jpg?itok=wFosMiws)
.jpg?itok=RlwQcjJv)
.jpg?itok=687vZA6k)
